GB0022569080 - Common Stock

Overall **DOX** gets a fundamental rating of **6** out of 10. We evaluated **DOX** against 85 industry peers in the **IT Services** industry. **DOX** has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. **DOX** has a correct valuation and a medium growth rate.

In the past year **DOX** was profitable.

Each year in the past 5 years **DOX** has been profitable.

In the past 5 years **DOX** always reported a positive cash flow from operatings.

The **Return On Equity** of **DOX** (**14.25%**) is better than **75.90%** of its industry peers.

The **Return On Invested Capital** of **DOX** (**12.81%**) is better than **85.54%** of its industry peers.

Measured over the past 3 years, the **Average Return On Invested Capital** for **DOX** is above the industry average of **8.93%**.

The 3 year average ROIC (**10.98%**) for **DOX** is below the current ROIC(**12.81%**), indicating increased profibility in the last year.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 7.81% | ||

ROE | 14.25% | ||

ROIC | 12.81% |

ROA(3y)9.07%

ROA(5y)8.8%

ROE(3y)16.48%

ROE(5y)15.34%

ROIC(3y)10.98%

ROIC(5y)10.9%

In the last couple of years the **Profit Margin** of **DOX** has grown nicely.

With an excellent **Operating Margin** value of **15.03%**, **DOX** belongs to the best of the industry, outperforming **84.34%** of the companies in the same industry.

In the last couple of years the **Operating Margin** of **DOX** has grown nicely.

In the last couple of years the **Gross Margin** of **DOX** has remained more or less at the same level.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 15.03% | ||

PM (TTM) | 10.02% | ||

GM | 35.22% |

OM growth 3Y1.3%

OM growth 5Y2.8%

PM growth 3Y-2.83%

PM growth 5Y4.21%

GM growth 3Y1.4%

GM growth 5Y0.37%

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so **DOX** is still creating some value.

The number of shares outstanding for **DOX** has been reduced compared to 1 year ago.

Compared to 5 years ago, **DOX** has less shares outstanding

The debt/assets ratio for **DOX** has been reduced compared to a year ago.

Looking at the **Altman-Z score**, with a value of **4.90**, **DOX** is in the better half of the industry, outperforming **73.49%** of the companies in the same industry.

Looking at the **Debt to FCF ratio**, with a value of **0.96**, **DOX** is in the better half of the industry, outperforming **79.52%** of the companies in the same industry.

A Debt/Equity ratio of **0.18** indicates that **DOX** is not too dependend on debt financing.

Looking at the **Debt to Equity ratio**, with a value of **0.18**, **DOX** is in the better half of the industry, outperforming **66.27%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.18 | ||

Debt/FCF | 0.96 | ||

Altman-Z | 4.9 |

ROIC/WACC1.35

WACC9.52%

A Current Ratio of **1.24** indicates that **DOX** should not have too much problems paying its short term obligations.

The **Current ratio** of **DOX** (**1.24**) is worse than **65.06%** of its industry peers.

The current and quick ratio evaluation for **DOX** is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.24 | ||

Quick Ratio | 1.24 |

The **Earnings Per Share** has been growing slightly by **7.96%** on average over the past years.

The Revenue for **DOX** has decreased by **-16.90%** in the past year. This is quite bad

EPS 1Y (TTM)6.57%

EPS 3Y10%

EPS 5Y7.96%

EPS Q2Q%3.18%

Revenue 1Y (TTM)-16.9%

Revenue growth 3Y5.44%

Revenue growth 5Y4.22%

Sales Q2Q%1.14%

Based on estimates for the next years, **DOX** will show a quite strong growth in **Earnings Per Share**. The EPS will grow by **9.23%** on average per year.

Based on estimates for the next years, **DOX** will show a small growth in **Revenue**. The Revenue will grow by **3.49%** on average per year.

EPS Next Y10.03%

EPS Next 2Y9.63%

EPS Next 3Y9.23%

EPS Next 5YN/A

Revenue Next Year2.37%

Revenue Next 2Y2.99%

Revenue Next 3Y3.49%

Revenue Next 5YN/A

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

A **Price/Earnings** ratio of **14.96** indicates a correct valuation of **DOX**.

When comparing the **Price/Earnings** ratio of **DOX** to the average of the S&P500 Index (**29.30**), we can say **DOX** is valued slightly cheaper.

A **Price/Forward Earnings** ratio of **12.98** indicates a correct valuation of **DOX**.

Based on the **Price/Forward Earnings** ratio, **DOX** is valued cheaper than 86.75% of the companies in the same industry.

The average S&P500 **Price/Forward Earnings** ratio is at **23.90**. **DOX** is valued slightly cheaper when compared to this.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 14.96 | ||

Fwd PE | 12.98 |

Compared to the rest of the industry, the **Enterprise Value to EBITDA** ratio of **DOX** indicates a somewhat cheap valuation: **DOX** is cheaper than 74.70% of the companies listed in the same industry.

Based on the **Price/Free Cash Flow** ratio, **DOX** is valued cheaper than 81.93% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 15.65 | ||

EV/EBITDA | 11.15 |

The excellent profitability rating of **DOX** may justify a higher PE ratio.

PEG (NY)1.49

PEG (5Y)1.88

EPS Next 2Y9.63%

EPS Next 3Y9.23%

With a **Yearly Dividend Yield** of **2.08%**, **DOX** has a reasonable but not impressive dividend return.

Compared to an average industry **Dividend Yield** of **2.85**, **DOX** pays a better dividend. On top of this **DOX** pays more dividend than 91.57% of the companies listed in the same industry.

Compared to an average S&P500 **Dividend Yield** of **2.21**, **DOX** has a dividend comparable with the average S&P500 company.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.08% |

On average, the dividend of **DOX** grows each year by **12.15%**, which is quite nice.

Dividend Growth(5Y)12.15%

Div Incr Years11

Div Non Decr Years11

DP41.87%

EPS Next 2Y9.63%

EPS Next 3Y9.23%

**AMDOCS LTD**

NASDAQ:DOX (11/8/2024, 8:00:01 PM)

After market: 92.17 0 (0%)**92.17**

**+0.03 (+0.03%) **

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustryIT Services

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap10.52B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.08% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 14.96 | ||

Fwd PE | 12.98 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)1.49

PEG (5Y)1.88

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 7.81% | ||

ROE | 14.25% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 15.03% | ||

PM (TTM) | 10.02% | ||

GM | 35.22% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.78

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.18 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.24 | ||

Quick Ratio | 1.24 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)6.57%

EPS 3Y10%

EPS 5Y

EPS Q2Q%

EPS Next Y10.03%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-16.9%

Revenue growth 3Y5.44%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y